Clinical Trial Update: Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis [Phase 2]

View source ↗

Summary

A Phase 2 completed trial evaluating erythropoietin as an add-on to methylprednisolone for safety and efficacy in acute optic neuritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• Erythropoietin (erythropoietin)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | Conditions: Optic Neuritis | Phase 2 | Status: COMPLETED